良性病变被误评为O-RADS US v2022 4类和5类的患病率及形态学分析
这项多中心回顾性研究纳入2011年至2014年间接受盆腔超声的连续患者,旨在确定良性病变被评分为O-RADS US 4和5类的频率及其影像特征。在219个评分为O-RADS US 4或5的病变中,135个为良性,84个为恶性;良性病变中最常见的是囊腺瘤和囊腺纤维瘤(46.7%),实性成分是最常见的影像特征(71.1%)。
要点
- 良性病变被评高分的最常见特征是实性成分(71.1%),其次是多房结构(45.2%)。
- 囊腺瘤和囊腺纤维瘤占良性高分病变的46.7%,是主要的假阳性来源。
关键影像表现/征象
- 良性病变被评分为O-RADS US 4或5类时,实性成分是最常见的特征(71.1%,96/135),其次为多房结构(45.2%,61/135)。
- O-RADS US 4类良性病变中实性成分占68.8%(77/112),O-RADS US 5类良性病变中实性成分占83%(19/23),两者差异无统计学意义(P = .22)。
临床应用与阅片要点
- 对于伴实性成分或多房结构的病变,需结合临床和其他影像学检查综合评估,减少不必要的干预。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 研究纳入2011-2014年病例,可能未完全反映当前O-RADS US v2022的实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Lesions scored as Ovarian-Adnexal Reporting and Data System (O-RADS) US 4 have an expected risk of malignancy of 10% to less than 50%, and those scored as O-RADS US 5 have an expected risk of malignancy of 50% or greater. However, studies of unselected populations demonstrated lower risk-of-malignancy ranges due to benign lesions being assigned these scores. Purpose To determine the frequency of benign lesions scored as O-RADS US 4 and 5 and to assess their pathologic and lexicon imaging features. Materials and Methods Consecutive patients who underwent pelvic US between January 2011 and December 2014 were included in this multicenter retrospective study (median age, 47 years [IQR, 36-56 years]). Investigators blinded to final outcome recorded O-RADS US 4 and 5 lesion lexicon features, which were analyzed and compared with the final outcome: histopathologic diagnosis, definitive characterization at CT or MRI, or complete resolution at follow-up imaging. Continuous and categorical variables were compared using the Mann-Whitney U test and Fisher exact test, respectively. Results Among 219 lesions scored as O-RADS US 4 and 5 in the study, 135 were benign and 84 were malignant at final outcome. Of the 135 benign lesions scored as O-RADS US 4 or 5, cystadenomas and cystadenofibromas (46.7%, 63 of 135) were the most common. Physiologic cysts, endometriomas, other benign nonneoplastic lesions, dermoids, fibromas, and fibrothecomas composed the remaining 53.3% (72 of 135). Per-lesion analysis demonstrated that solid component was the most common feature of benign lesions scored as O-RADS US 4 or 5 (71.1%, 96 of 135), followed by multilocularity (45.2%, 61 of 135). Analysis according to O-RADS score demonstrated that solid component was the most common feature of both O-RADS US 4 benign lesions (68.8%, 77 of 112) and O-RADS US 5 benign lesions (83%, 19 of 23) (P = .22). Conclusion Approximately half of the benign lesions scored as O-RADS US 4 or 5 were cystadenomas or cystadenofibromas, followed by nonneoplastic lesions (including physiologic cysts and endometriomas) and benign neoplasms (dermoids). A solid component was the most frequent imaging observation of benign lesions scored as O-RADS US 4 or 5. © RSNA, 2026.
引用
- Jha P, Sadowski EA, Gupta A, et al. Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis. Radiology. 2026. PMID: 42117989. doi:10.1148/radiol.252310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。